Orthocell Limited is a regenerative medicine company developing therapies for soft tissue repair and nerve regeneration. Its products target musculoskeletal conditions, aiming to improve patient recovery outcomes.
Ticker code: None
Sector: Healthcare | Industry: Biotechnology | Website: https://orthocell.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $283,244,994 | $252,252,976 | 246300000.0 | 84.37 | $238,979,511 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 24 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $14,778,000 | $28,619,928 | $576,895 | 0.0 | -181.6 | -189.8 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| None | None | $144,803 | $684,741 | 0.02 | 0.1 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $1.150 | 0.4 | 1.8 | -6.1 | -8.7 | -7.3 | 155.6 |
None Price Chart with Volume and 3EMA
None Short Positions
Click HERE to understand why the above moving averages have been chosen.